PIER 88 INVESTMENT PARTNERS LLC

Position in RCKT — Rocket Pharmaceuticals, Inc.

CIK 1697366 SAN FRANCISCO, CA

Position in RCKT

as of Mar 31, 2026 · filed May 11, 2026 Compact

Position Value

$194,036

+$25,978 QoQ

Shares Held

54,200

+13.2% QoQ

Ownership

0.050%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

PIER 88 INVESTMENT PARTNERS LLC holds $8,185,124 across 11 Biotechnology names. RCKT ranks #11 (2.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LGND	Ligand Pharmaceuticals Inc	8,000	$1,597,200
2	DNLI	Denali Therapeutics Inc.	64,800	$1,244,160
3	HALO	Halozyme Therapeutics, Inc.	19,000	$1,227,970
4	KRYS	Krystal Biotech, Inc.	3,500	$904,120
5	MDGL	Madrigal Pharmaceuticals, Inc.	1,200	$628,164
6	ABSI	Absci Corp	206,100	$618,300
7	BBIO	BridgeBio Pharma, Inc.	7,700	$571,802
8	INSM	INSMED Inc	3,200	$523,264

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$194,036	54,200	+13.2%	Shares	Sole	2026-05-11
2025-12-31	$168,058	47,880	+320.7%	Shares	Sole	2026-02-04
2025-09-30	$37,098	11,380	0.0%	Shares	Sole	2025-10-31
2025-06-30	$27,881	11,380	-80.0%	Shares	Sole	2025-08-07
2025-03-31	$378,989	56,820	+51.5%	Shares	Sole	2025-05-06
2024-12-31	$471,375	37,500	+15.4%	Shares	Sole	2025-02-12
2024-09-30	$600,090	32,490	+5.1%	Shares	Sole	2024-11-06
2024-06-30	$665,277	30,900	+71.7%	Shares	Sole	2024-08-06
2024-03-31	$484,920	18,000	0.0%	Shares	Sole	2024-05-10
2023-12-31	$539,460	18,000	0.0%	Shares	Sole	2024-02-12
2023-09-30	$368,820	18,000	—	Shares	Sole	2023-11-09
No filing history on record for this holder in this stock.